Skip to content

Yu Fan

Follow

13F filer, CIK 1668029, CENTRAL, HONG KONG, Hong Kong

Yu Fan reported $94,920,432 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-463618

Period
2026-09-30
Reported value
$94.9M
Holdings
6
Top 10 weight
100%
New
0
Sold out
2

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ALMSexited-252,672-$7.11M
CBLLexited-342,398-$6.66M
ABTCreduced-287,538-$2.44M
WHWKreduced-31,916-$120K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-463618, largest first. % of portfolio is the value over $94,920,432, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KMTSKESTRA MED TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,282,519 shares; 2025Q2: 2,282,519 shares; 2025Q3: 2,282,519 shares; 2025Q4: 2,282,519 shares; 2026Q1: 2,282,519 shares; 2026Q2: 2,282,519 shares; 2026Q3: 2,282,519 shares 2,282,519$64.6M68.03%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,070,000 shares; 2025Q2: 2,070,000 shares; 2025Q3: 2,070,000 shares; 2025Q4: 2,070,000 shares; 2026Q1: 2,070,000 shares; 2026Q2: 4,861,314 shares; 2026Q3: 4,829,398 shares 4,829,398$18.2M19.13%-31,916Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000$5.54M5.83%0Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 329,760 shares; 2026Q2: 329,760 shares; 2026Q3: 329,760 shares 329,760$3.58M3.77%0Timeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,055,409 shares; 2026Q2: 1,055,409 shares; 2026Q3: 1,055,409 shares 1,055,409$2.9M3.06%0Timeline
ABTCAMERICAN BITCOIN CORP.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 308,076 shares; 2026Q2: 308,076 shares; 2026Q3: 20,538 shares 20,538$174K0.18%-287,538Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALMSALUMIS INC252,672$7.11Mshares
CBLLCERIBELL INC342,398$6.66Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-463618 base2026-11-16

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-463618 Quarter ended 2026-09-302026-11-16
13F-HR 0001193125-26-352356 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001193125-26-227546 Quarter ended 2026-03-312026-05-18acceptance time not in the bulk data set
13F-HR 0001193125-26-055455 Quarter ended 2025-12-312026-02-18acceptance time not in the bulk data set
13F-HR 0001193125-25-283155 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000950123-25-008426 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0000950123-25-005584 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0000950123-25-002400 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000950123-24-011471 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0000950123-24-008418 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000950123-24-005233 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000950123-24-002149 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0000950123-23-010790 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0000950123-23-008115 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0000950123-23-004998 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000950123-23-002328 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0000950123-22-011718 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0000950123-22-009122 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0000950123-22-005937 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0000950123-22-002424 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0000950123-21-015119 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR/A 0000950123-21-012428 Quarter ended 2021-06-302021-09-17acceptance time not in the bulk data set
13F-HR/A 0000950123-21-012427 Quarter ended 2021-03-312021-09-17acceptance time not in the bulk data set
13F-HR 0000950123-21-011094 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR/A 0000950123-21-006743 Quarter ended 2020-12-312021-05-17acceptance time not in the bulk data set
13F-HR 0000950123-21-006750 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0000950123-21-002356 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set